Abstract
Rationale
d-Serine is an endogenous co-agonist of the N-methyl-d-aspartate (NMDA) receptor and has been suggested to improve cognitive deficits in schizophrenia.
Objectives
The present study investigates the effects of treatment with d-serine in mice on tasks that require recognition learning and working memory, two cognitive domains that are impaired in schizophrenia.
Methods
We studied the effects of various regimens of systemic administration of d-serine (50 mg/kg/day) on BALB/c mice performing object recognition, T-maze alternation, and open-field exploration tasks. For the object recognition task, we also contrasted the effects of d-serine and d-cycloserine and investigated whether d-serine could reverse alterations induced by subchronic injections of the NMDA antagonist MK-801. d-Serine levels after injections were measured by high-performance liquid chromatography.
Results
In the object recognition task, pre-training treatment with d-serine or d-cycloserine significantly enhanced recognition memory 24 h after training. A single administration of d-serine 30 min (but not 6 h) after training produced similar enhancement, suggesting an effect on memory consolidation. Daily treatment with d-serine enhanced both object recognition and T-maze performance over multiple days and improved short-term memory in MK-801-treated mice. d-Serine treatment did not alter open-field exploration. Behavioral effects were accompanied by increased levels of d-serine in the hippocampus of treated animals.
Conclusions
Our results show that treatment with d-serine can improve performance in tasks related to recognition learning and working memory, suggesting that this agent can be useful for the treatment of disorders involving declines in these cognitive domains.
Similar content being viewed by others
References
Akirav I, Maroun M (2006) Ventromedial prefrontal cortex is obligatory for consolidation and reconsolidation of object recognition memory. Cereb Cortex 16:1759–1765
Assini FL, Duzzioni M, Takahashi RN (2009) Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation. Behav Brain Res 204:206–211
Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, Agam G (2007) A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res 90:41–51
Brigman JL, Ihne J, Saksida LM, Bussey TJ, Holmes A (2009) Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL/6J mice. Front Behav Neurosci 3:2
Brooks SP, Pask T, Jones L, Dunnett SB (2005) Behavioural profiles of inbred mouse strains used as transgenic backgrounds. II. Cognitive tests. Genes Brain Behav 4:307–317
Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3:241–253
de Lima MNM, Laranja DC, Bromberg E, Roesler R, Schröder N (2005) Pre- or post- training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res 156:139–143
Duffy S, Labrie V, Roder JC (2008) D-Serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacology 33:1004–1018
Fishkin RJ, Ince EC, Carlezon WA, Dunn RW (1993) D-Cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behav Neural Biol 59:150–157
Folley BS, Astur R, Jagannathan K, Calhoun VD, Pearlson GD (2010) Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage 49:3373–3384
Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF (2008) Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res 106:320–327
Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321–330
Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72:41–51
Habl G, Zink M, Petroianu G, Bauer M, Schneider-Axmann T, von Wilmsdorff M, Falkai P, Henn F, Schmitt A (2009) Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. J Neural Transm 116:1657–1665
Hashimoto A, Nishikawa T, Oka T, Takahashi K, Hayashi T (1992) Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J Chromatogr 6:41–48
Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, S-i O, Hasegawa H, Imai K, Iyo M (2003) Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D- aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60:572–576
Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindström LH, Iyo M (2005) Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 29:767–769
Hashimoto K, Fujita Y, Ishima T, Chaki S, Iyo M (2008) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine. Eur Neuropsychopharmacol 18:414–421
Hashimoto K, Fujita Y, Horio M, Kunitachi S, Iyo M, Ferraris D, Tsukamoto T (2009) Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry 65:1103–1106
Henneberger C, Papouin T, Oliet SHR, Rusakov DA (2010) Long-term potentiation depends on release of D-serine from astrocytes. Nature 463:232–236
Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M (2005) D-Serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 57:577–585
Izquierdo I, Bevilaqua LRM, Rossato JI, Bonini JS, Medina JH, Cammarota M (2006) Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci 29:496–505
Jentsch J, Roth R (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201–225
Kanahara N, Shimizu E, Ohgake S, Fujita Y, Kohno M, Hashimoto T, Matsuzawa D, Shirayama Y, Hashimoto K, Iyo M (2008) Glycine and D-serine, but not D-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801. Psychopharmacology 198:363–374
Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckiw RF, D'Souza C, Saksa J, Woods SW, Javitt DC (2010) High dose D-serine in the treatment of schizophrenia. Schizophr Res 121:125–130
Karasawa J, Hashimoto K, Chaki S (2008) D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res 186:78–83
Kart-Teke E, De Souza Silva MA, Joseph P, Huston JP, Dere E (2006) Wistar rats show episodic-like memory for unique experiences. Neurobiol Learn Mem 85:173–182
Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA (2007) Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry 64:633–647
Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH (2007) NMDA receptors and schizophrenia. Curr Opin Pharmacol 7:48–55
Labrie V, Clapcote SJ, Roder JC (2009) Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors. Pharmacol Biochem Behav 91:610–620
Lipina T, Labrie L, Weiner I, Roder J (2005) Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology 179:54–67
Madeira C, Freitas ME, Vargas-Lopes C, Wolosker H, Panizzutti R (2008) Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res 101:76–83
Meyer RC, Knox J, Purwin DA, Spangler EL, Ingram DK (1998) Combined stimulation of the glycine and polyamine sites of the NMDA receptor attenuates NMDA blockade-induced learning deficits of rats in a 14-unit T-maze. Psychopharmacology 135:290–295
Mothet J-P, Parent AT, Wolosker H, Brady RO, Linden DJ, Ferris CD, Rogawski MA, Snyder SH (2000) D-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 97:4926–4931
Mouri A, Noda Y, Enomoto T, Nabeshima T (2007) Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 51:173–184
Nakazawa K, McHugh TJ, Wilson MA, Tonegawa S (2004) NMDA receptors, place cells and hippocampal spatial memory. Nat Rev Neurosci 5:361–372
Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128:419–432
Nilsson M, Carlsson A, Carlsson ML (1997) Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J Neural Transm 104:1195–1205
Panizzutti R, Rausch M, Zurbrügg S, Baumann D, Beckmann N, Rudin M (2005) The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain. Neurosci Lett 380:111–115
Parnas AS, Weber M, Richardson R (2005) Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem 83:224–231
Quartermain D, Mower J, Rafferty MF, Hertng RL, Lanthorn TH (1994) Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol 257:7–12
Riedel G, Platt B, Micheau J (2003) Glutamate receptor function in learning and memory. Behav Brain Res 140:1–47
Rossato JI, Bonini JS, Coitinho AS, Vianna MR, Medina JH, Cammarota M, Izquierdo I (2004) Retrograde amnesia induced by drugs acting on different molecular systems. Behav Neurosci 3:563–568
Schmitt ML, Coelho W, Lopes-de-Souza AS, Guimarães FS, Carobrez AP (1995) Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats. Neurosci Lett 189:93–96
Shimazaki T, Kaku A, Chaki S (2010) D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats. Psychopharmacology 209:263–270
Shimizu E, Tang Y-P, Rampon C, Tsien JZ (2000) NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. Science 290:1170–1174
Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A (2003) Performance of different mouse strains in an object recognition task. Behav Brain Res 147:49–54
Steffek AE, Haroutunian V, Meador-Woodruff JH (2006) Serine racemase protein expression in cortex and hippocampus in schizophrenia. Neuroreport 17:1181–1185
Stouffer EM, Petri HL, Devan BD (2004) Effect of D-serine on a delayed match-to-place task for the water maze. Behav Brain Res 152:447–452
Sunyer B, Patil S, Frischer C, Hoeger H, Lubec G (2008) Strain-dependent effects of cognitive enhancers in the mouse. Amino Acids 34:485–495
Tsai GE, Lin PY (2010) Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr Pharm Des 5:522–537
Tsai G, Yang P, Chung L-C, Lange N, Coyle JT (1998) D-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44:1081–1089
Tuominen HJ, Tiihonen J, Wahlbeck K (2005) Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr Res 72:225–234
Vargas-Lopes C, Madeira C, Kahn SA, Albino do Couto I, Bado P, Houzel JC, De Miranda J, de Freitas MS, Ferreira ST, Panizzutti R (2011) Protein kinase C activity regulates D-serine availability in the brain. J Neurochem 116:281–290
Werner-Seidler A, Richardson R (2007) Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine. Biol Psychiatry 62:1195–1197
Winters BD, Bussey TJ (2005) Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory. J Neurosci 25:4243–4251
Yang Y, Ge W, Chen Y, Zhang JM, Chen Y, Wu CP, Poo MM, Duan S (2003) Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc Natl Acad Sci USA 100:15194–15199
Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA (2009) Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122:150–202
Zhang Z, Gong N, Wang W, Xu L, Xu T-L (2008) Bell-shaped D-serine actions on hippocampal long-term depression and spatial memory retrieval. Cereb Cortex 18:2391–2401
Zlomuzica A, De Souza SM, Huston J, Dere E (2007) NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice. Psychopharmacology 193:503–509
Acknowledgments
This work was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundação Universitária José Bonifácio, and International Society for Neurochemistry to R.P. and by grants from FAPERJ and CNPq to O.B.A. R.P. is recipient of a Long-Term Fellowship from the Human Frontier Science Program. P.B. and L.M. were supported by undergraduate scholarships from FAPERJ. C.V.L. and C.M. were supported by pre-doctoral fellowships from CNPq. We are grateful to Ana Cláudia Rangel for technical assistance and to Jean Christophe Houzel for encouragement.
Conflicts of interest
The authors declare that all experiments complied with current Brazilian laws and report no conflicts of interest concerning the work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bado, P., Madeira, C., Vargas-Lopes, C. et al. Effects of low-dose d-serine on recognition and working memory in mice. Psychopharmacology 218, 461–470 (2011). https://doi.org/10.1007/s00213-011-2330-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-011-2330-4